RESTRICTION OF INTERFERON-GAMMA RESPONSIVENESS AND BASAL EXPRESSION OF THE MYELOID HUMAN FC-GAMMA-R1B GENE IS MEDIATED BY A FUNCTIONAL PU.1 SITE AND A TRANSCRIPTION INITIATOR CONSENSUS

被引:108
作者
EICHBAUM, QG [1 ]
IYER, R [1 ]
RAVEH, DP [1 ]
MATHIEU, C [1 ]
EZEKOWITZ, RAB [1 ]
机构
[1] HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV INFECT DID & HEMATOL ONCOL,BOSTON,MA 02115
关键词
D O I
10.1084/jem.179.6.1985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The restricted expression of the human Fc gamma R1b gene to myeloid cells is likely to be regulated by a combination of transcription factors that may not be solely expressed in myeloid cells, but act together to restrict the expression of the gene to myeloid cells. Low basal expression of the human Fc gamma R1b gene is specifically upregulated by interferon gamma (IFN-gamma). A 181-bp region of 5' flanking sequence contains several key regulatory motifs that include the extended gamma response region (XGRR) and the PIE region. The XGRR contains the 39-bp gamma response region originally defined in the highly homologous Fc gamma R1a gene. The XGRR is in close proximity to the 21-bp PIE motif that is conserved in the promoters of some other myeloid genes. The PIE motif contains a consensus site for the macrophage and B cell transcription factor, PU.1, and is adjacent to the cluster of transcription start sites. An active transcription initiator, Inr, consensus spans the start sites and appears to direct transcription initiation of this TATA-less gene. In this study, we demonstrate that the PIE region contains a functional PU.1 site that binds a human PU.1-like protein and that associated factors present in myeloid extracts also bind in this PIE region. Mutational analysis reveals an absolute requirement for an intact PU.1 box for both basal and IFN-gamma inducible expression of this gene. In addition, mutations in the Inr greatly reduce basal and inducible transcription. Insertion of a strong TATA box downstream from the Inr or at -30 bp from the transcription start sites restores basal and inducible activity in the presence of a mutated PU.1 site. We also demonstrate that indeed, when the XGRR is positioned in the context of a heterologous TATA containing promoter, it is able to respond equivalently to either IFN-alpha or IFN-gamma. However, IFN-alpha responsiveness does not occur in the context of the physiological Fc gamma R1b TATA-less basal promoter. Our results suggest that a human PU.1-like factor acts as a ''bridging factor'' between the upstream IFN-gamma enhancer and the Inr dependent preinitiation complex. These findings indicate that the structure of the basal promoter in combination with restricted activators like PU.1 are important in regulating the expression of this gene.
引用
收藏
页码:1985 / 1996
页数:12
相关论文
共 55 条
[1]  
ALCALAY M, 1990, ONCOGENE, V5, P267
[2]  
AUGET M, 1988, CELL, V55, P273
[3]   DEFINITION OF INTERFERON-GAMMA RESPONSE ELEMENTS IN A NOVEL HUMAN FC-GAMMA RECEPTOR GENE (FC-GAMMA-RIB) AND CHARACTERIZATION OF THE GENE STRUCTURE [J].
BENECH, PD ;
SASTRY, K ;
IYER, RR ;
EICHBAUM, QG ;
RAVEH, DP ;
EZEKOWITZ, RAB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1115-1123
[4]  
BENOIST C, 1990, ANNU REV IMMUNOL, V9, P457
[5]   THE PU.1/SPI-1 PROTOONCOGENE IS A TRANSCRIPTIONAL REGULATOR OF A LENTIVIRUS PROMOTER [J].
CARVALHO, M ;
DERSE, D .
JOURNAL OF VIROLOGY, 1993, 67 (07) :3885-3890
[6]  
CHEN HM, 1993, J BIOL CHEM, V268, P8230
[7]   THE TATA-BINDING PROTEIN IS REQUIRED FOR TRANSCRIPTION BY ALL 3 NUCLEAR-RNA POLYMERASES IN YEAST-CELLS [J].
CORMACK, BP ;
STRUHL, K .
CELL, 1992, 69 (04) :685-696
[8]   RAPID ACTIVATION BY INTERFERON-ALPHA OF A LATENT DNA-BINDING PROTEIN PRESENT IN THE CYTOPLASM OF UNTREATED CELLS [J].
DALE, TC ;
IMAM, AMA ;
KERR, IM ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1203-1207
[9]   CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR [J].
DECKER, T ;
LEW, DJ ;
MIRKOVITCH, J ;
DARNELL, JE .
EMBO JOURNAL, 1991, 10 (04) :927-932
[10]  
DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582